Home Subscription Services

Quintessence International
QI Home Page
About the Editor
Editorial Board
Accepted Manuscripts
Author Guidelines
Submission Form
Reprints / Articles
Quintessence Publishing: Journals: QI
Quintessence International

Edited by Eli Eliav

ISSN 0033-6572 (print) • ISSN 1936-7163 (online)

January 2012
Volume 43 , Issue 1

Share Abstract:

A study to evaluate the efficacy of toluidine blue and cytology in detecting oral cancer and dysplastic lesions

Farzan Rahman, MDS/Shoaib R. Tippu, MDS/Suneet Khandelwal, MDS/K.L. Girish, MDS/B.C. Manjunath, MDS/Akshay Bhargava, BDS

Pages: 5159
PMID: 22259809

Objective: Recent advances in techniques for detecting oral premalignant lesions and oral squamous cell carcinoma have improved the chances of early diagnosis. Adjuncts for detection of lesions include toluidine blue staining and cytologic examination. The primary objective of this study was to assess the efficacy of 1% toluidine blue (modified Mashberg technique) and cytology in detection of oral premalignant lesions and oral squamous cell carcinoma. Method and Materials: The study included 86 participants suspected of having oral premalignant lesions or oral squamous cell carcinoma. One percent toluidine blue was applied to the lesions, followed by cytology. A biopsy was then performed on the tissue. Histopathologically proven oral premalignant lesions/oral squamous cell carcinoma lesions were analyzed for sensitivity, specificity, postive predictive value, and negative predictive value of both screening techniques. The association of screening techniques and histopathologic diagnosis among the oral premalignant lesions, oral squamous cell carcinoma, and benign groups were analyzed using the Fisher exact test. P < .05 was considered significant. Results: The specificity and sensitivity for oral squamous cell carcinoma and oral premalignant lesions detection of 1% toluidine blue was 81.35% and 66.67%, respectively, while cytology attained 77.97% and 70.37%, respectively. Negative predictive value and positive predictive value were 84.21% and 62.06% for 1% toluidine blue and 85.18% and 59.37% for cytologic examination, respectively. Comparison of 1% toluidine blue and cytology with histopathologic diagnosis shows a significant difference between carcinoma/epithelial dysplasia and no dysplasia and carcinoma/epithelial dysplasia and benign lesions (all, P < .05). Conclusion: The results of this study suggest that 1% toluidine blue and cytology have high sensitivity, specificity, and accuracy in detecting oral premalignant lesions and oral squamous cell carcinoma and can be used as an adjunct for early detection of such lesions. (Quintessence Int 2012;43:5159)

Key words: cytology, oral cancer, premalignant, screening, toluidine blue

Full Text PDF File | Order Article


Get Adobe Reader
Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.
  © 2017 Quintessence Publishing Co Inc

Home | Subscription Services | Books | Journals | Multimedia | Events | Blog
Terms of Use | Privacy Policy | About Us | Contact Us | Advertising | Help | Sitemap | Catalog